Fig. 2.

Immune signatures of TIME impact on survival of OPSCC patients. A-C Kaplan-Meier survival curves for disease-free survival according to high/low gene expression-based cell types and pathways profiling (classification based on median expression as cut-off), in (A) all OPSCC patients (n = 39), (B) HPV-positive (n = 24) and (C) HPV-negative patients (n = 15). Log-rank statistics were performed to determine significance; p values, hazard ratios (HR) and 95% confidence intervals (CI) are reported in each graph